HEPATITIS B FOUNDATION (EIN 232655669) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1991

Legal Domicile

Principal Officer

LOUIS P KASSA III

Phone

2154894900

Tax Period

2024-07-01 to 2025-06-30

HEPATITIS B FOUNDATION, founded in 1991, is a community nonprofit in the Diseases & Disorders sector that reported $3.5M in total revenue in fiscal year 2024. Revenue grew 10% year-over-year, indicating healthy expansion. Expenses of $3.3M left a modest 6% surplus.

Mission

THE MISSION OF THE HEPATITIS B FOUNDATION IS TO FIND A CURE FOR HEPATITIS B AND IMPROVE THE QUALITY OF LIFE FOR THOSE AFFECTED WORLDWIDE THROUGH RESEARCH, EDUCATION AND PATIENT ADVOCACY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $2,332,086

Program Service Revenue $684,246

Investment Income $293,070

Other Revenue $157,178

TOTAL REVENUE $3,466,580

Expense Breakdown

Grants Paid $114,096

Salaries & Benefits $1,909,823

Fundraising Expenses $560,785

Program Expenses $2,476,170

Other Expenses $1,226,905

TOTAL EXPENSES $3,250,824

Year-over-Year Comparison

	2024	2023	Change
Revenue	$3,466,580	$3,147,035	+0.1%
Expenses	$3,250,824	$3,098,136	+0.0%
Net Income	$215,756	$48,899	+3.4%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$654,722

Total Directors

$654,722

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
TIMOTHY M BLOCK PHD	CHAIRMAN	0.50	Officer Director	$0	$1,194	$37,092
LOUIS P KASSA III MPA	CHIEF EXECUTIVE OFFICER	10.00	Officer Director	$0	$40,371	$355,270
CHARI COHEN PHD	PRESIDENT	40.00	Officer Director	$220,197	$42,163	$262,360
JOEL ROSEN ESQ	VICE-CHAIR	0.50	Officer Director	$0	$0	$0
ELIZABETH SEEBER MBA	TREASURER	0.50	Officer Director	$0	$0	$0
STANLEY BROADBENT	DIRECTOR	0.50	Director	$0	$0	$0
CAROL BROSGART MD	DIRECTOR	0.50	Director	$0	$0	$0
NATHANIEL BROWN MD	DIRECTOR	0.50	Director	$0	$0	$0
GANG CHEN MD PHD	DIRECTOR	0.50	Director	$0	$0	$0
LILLIAN CHIANG PHD MBA	DIRECTOR	0.50	Director	$0	$0	$0
DAVID GRUBER CPA	DIRECTOR	0.50	Director	$0	$0	$0
RAMAN KAPUR MBA	DIRECTOR	0.50	Director	$0	$0	$0
MARK PETTY	DIRECTOR	0.50	Director	$0	$0	$0
LEWIS ROBERTS MB CHB PHD	DIRECTOR	0.50	Director	$0	$0	$0
LU-YU HWANG MD	DIRECTOR	0.50	Director	$0	$0	$0
ELIZABETH SIGETY	DIRECTOR	0.50	Director	$0	$0	$0
WALTER TSOU MD	DIRECTOR	0.50	Director	$0	$0	$0
SU WANG MD MPH	DIRECTOR	0.50	Director	$0	$0	$0
HEATHER DAVIS	DIRECTOR	0.50	Director	$0	$0	$0
JOE ERCKERT	CHIEF DEVELOPMENT OFFICER	40.00	Highest	$110,856	$59,312	$170,168

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$3,466,580	$3,250,824	$20,490,190	$215,756
2024	No data	No data	No data	No data
2023	$2,988,379	$2,845,275	$20,224,712	$143,104
2022	$2,640,688	$2,374,928	$16,299,322	$265,760
2021	$2,860,673	$1,701,619	$11,952,203	$1,159,054
2020	$2,054,940	$1,873,880	$10,026,183	$181,060
2020	$2,054,940	$1,873,880	$10,026,183	$181,060
2019	$1,945,843	$1,854,464	$9,602,199	$91,379
2018	$1,961,334	$1,848,123	$8,509,851	$113,211

HEPATITIS B FOUNDATION